HK:2190 Stock Latest News
Company AnnouncementsZylox-Tonbridge Delivers Strong Interim Growth on High-Margin Vascular Devices2M ago
Company AnnouncementsZylox-Tonbridge Schedules Board Meeting to Approve Interim Results2M ago
Company AnnouncementsZylox-Tonbridge Updates H Share Buyback, Signals Confidence in Long-Term Prospects4M ago- Company AnnouncementsZylox-Tonbridge Details Valuation Basis for Remaining Stake in Vascular Device Platform5M ago
- Company AnnouncementsZylox-Tonbridge Shareholders Approve All Proposals at 2025 AGM5M ago
Company AnnouncementsZylox-Tonbridge Details Board and Committee Structure in Governance Update5M agoCompany AnnouncementsZylox-Tonbridge Updates 2025 Final Dividend Terms and Tax Treatment for H Shareholders5M ago
Company AnnouncementsZylox-Tonbridge Sets 2025 AGM to Vote on Profit Plan, Capital Mandates and Governance Changes6M ago
Company AnnouncementsZylox-Tonbridge Sets Final 2025 Dividend and Confirms Payout Timetable6M ago
Company AnnouncementsZylox-Tonbridge Grants 400,000 Share Options Under 2025 Incentive Scheme6M ago
Company AnnouncementsZylox-Tonbridge Reshapes Concert Party, Clarifies 24.61% Voting Bloc7M ago- Company AnnouncementsZylox-Tonbridge Seeks to Expand and Extend 2021 H Share Incentive Scheme7M ago
Company AnnouncementsZylox-Tonbridge Sets Governance Rules for Board Nomination Committee7M agoCompany AnnouncementsZylox-Tonbridge Moves to Full Ownership of Target Company in EUR 41 Million Deal7M ago
- Company AnnouncementsZylox-Tonbridge Proposes Final Cash Dividend for 20257M ago
Company AnnouncementsZylox-Tonbridge Plans Governance Overhaul, Seeks to Scrap Supervisory Committee7M ago- Company AnnouncementsZylox-Tonbridge Sets Detailed Governance Rules for Audit Committee7M ago
- Company AnnouncementsZylox-Tonbridge Profit Soars on Strong Neurovascular and Peripheral Device Growth in 20257M ago
Company AnnouncementsZylox-Tonbridge Proposes 2025 Final Dividend and Sets Key Dates7M agoCompany AnnouncementsZylox-Tonbridge Sets March Board Meeting to Review 2025 Results and Final Dividend8M ago
Company AnnouncementsZylox-Tonbridge Details Strategic Rationale for 49% Stake in European-Focused Medtech Group8M ago